RPL39P5
Putative ribosomal protein eL39-like 5
Also known as: R39L5_HUMAN
Protein identityUniProt · HPA
OverviewNCBI Gene
No narrative summary is available for RPL39P5 in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
51 residues, UniProt reviewed canonical sequence.
>Q59GN2|RPL39P5
1 MSSHKTFKIK QFLAKKQKQN RPIPQWIRMK TGNKIRYNSK RRHWKRTKLG LLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RPL39P5 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.5
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RPL39P5 as an antibody target. Whether an autoantibody or antibody against RPL39P5 could matter depends on whether native RPL39P5 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RPL39P5 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label RPL39P5 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...